Exxe Appointed as Italian Distributor

Just received a newsletter from ADO, not sure why this isn't announced on the ASX:

AnteoTech welcomes EXXE S.r.l (EXXE) to the EuGeni family. Based in Milan, Italy, EXXE is AnteoTech's fifth European distributor for the EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT).

We are excited at the ongoing momentum shown by the rapid expansion of our distributor base in Europe as we continue to lay the foundations for our EuGeni platform rollout. Italy is a key market for AnteoTech as the country's medical institutions have adopted point of care testing at high rates. In addition, the Italian Government is allowing pharmacies to administer rapid antigen testing for COVID-19, and this presents opportunities for the unique attributes of the EuGeni platform. The current COVID-19 situation in Italy is an avenue for readers to be distributed in the country, creating a ready market as we seek to roll out our COVID-19 Flu A Flu B multiplex test and Sepsis tests next year.

EXXE has a strong, established customer network throughout Italy. The EuGeni Antigen RDT will be EXXE’s first reader-based test for COVID-19. AnteoTech looks forward to working with EXXE over the coming weeks to submit the product registration with the Italian Ministry of Health and, in parallel, provide sales, marketing and technical training.